Andrew A. Jarjour

Andrew A. Jarjour

Auto-generated profile, based on publicly available information

Andrew A. Jarjour

MSD (UK) Ltd, London, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2010 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JHJeffrey K Huang
Jeffrey K Huang
AJAndrew A Jarjour
Andrew A Jarjour
BOBrahim Nait Oumesmar
Brahim Nait Oumesmar
CKChristophe Kerninon
Christophe Kerninon
AWAnna Williams
Anna Williams
RFRobin J M Franklin
Robin J M Franklin

1 June 2010 in The American Journal of Pathology
Verified
Journal Article
Closed access
VMVeronique Miron
Veronique Miron
SLSamuel K. Ludwin
Samuel K. Ludwin
PDPeter Darlington
Peter Darlington
AJAndrew A. Jarjour
Andrew A. Jarjour
BSBetty Soliven
Betty Soliven
JAJack P. Antel
Jack P. Antel

1 May 2003 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
AJAndrew A. Jarjour
Andrew A. Jarjour
CMColleen Manitt
Colleen Manitt
SMSimon W. Moore
Simon W. Moore
KTKatherine M. Thompson
Katherine M. Thompson
SYSung-Joo Yuh
Sung-Joo Yuh
TKTimothy E. Kennedy
Timothy E. Kennedy
Netrin-1, secreted by floor plate cells, orients axon extension in relation to the ventral midline of the embryonic spinal cord. Oligodendrocyte precursor (OP) cells are born close to the ventral midline and migrate away from the floor plate. Here we show that OP cells, identified by expression of the platelet-derived growth factor α receptor, express the netrin receptors dcc andunc5h1 but do not express netrin-1. Using a microchemotaxis assay, we demonstrate that migrating OPs are repelled by a gradient of netrin-1 in vitro. Furthermore, application of netrin-1 to OPs in vitro triggers retraction of OP processes. In the absence of netrin-1 or Deleted in Colorectal Cancer (DCC) function in vivo, fewer OP cells migrate from the ventral to the dorsal embryonic spinal cord, consistent with netrin-1 acting as a repellent. In addition to their role regulating cell movement, DCC and UNC-5 homologs have been suggested to function as proapoptotic dependence receptors, triggering cell death in the absence of netrin-1. In contrast, we report no evidence of increased OP cell death in vivo or in vitro in the absence of either netrin-1 or DCC. These findings indicate that netrin-1 is a repellent cue for migrating OPs in the embryonic spinal cord.

7 December 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AFAlerie Guzman de la Fuente
Alerie Guzman de la Fuente
OEOihana Errea
Oihana Errea
PWPeter van Wijngaarden
Peter van Wijngaarden
GGGinez A. Gonzalez
Ginez A. Gonzalez
CKChristophe Kerninon
Christophe Kerninon
RFRobin J.M. Franklin
Robin J.M. Franklin
The mechanisms regulating differentiation of oligodendrocyte (OLG) progenitor cells (OPCs) into mature OLGs are key to understanding myelination and remyelination. Signaling via the retinoid X receptor γ (RXR-γ) has been shown to be a positive regulator of OPC differentiation. However, the nuclear receptor (NR) binding partner of RXR-γ has not been established. In this study we show that RXR-γ binds to several NRs in OPCs and OLGs, one of which is vitamin D receptor (VDR). Using pharmacological and knockdown approaches we show that RXR–VDR signaling induces OPC differentiation and that VDR agonist vitamin D enhances OPC differentiation. We also show expression of VDR in OLG lineage cells in multiple sclerosis. Our data reveal a role for vitamin D in the regenerative component of demyelinating disease and identify a new target for remyelination medicines.

1 July 2011 in Experimental Neurology
Verified
Journal Article
Open access
HZHui Zhang
Hui Zhang
AJAndrew A. Jarjour
Andrew A. Jarjour
ABAmanda Boyd
Amanda Boyd
AWAnna Williams
Anna Williams
Multiple sclerosis is a demyelinating disease of the central nervous system which only affects humans. This makes it difficult to study at a molecular level, and to develop and test potential therapies that may change the course of the disease. The development of therapies to promote remyelination in multiple sclerosis is a key research aim, to both aid restoration of electrical impulse conduction in nerves and provide neuroprotection, reducing disability in patients. Testing a remyelination therapy in the many and various in vivo models of multiple sclerosis is expensive in terms of time, animals and money. We report the development and characterisation of an ex vivo slice culture system using mouse brain and spinal cord, allowing investigation of myelination, demyelination and remyelination, which can be used as an initial reliable screen to select the most promising remyelination strategies. We have automated the quantification of myelin to provide a high content and moderately-high-throughput screen for testing therapies for remyelination both by endogenous and exogenous means and as an invaluable way of studying the biology of remyelination.

1 February 2009 in Development
Verified
Journal Article
Open access
PDF file
SRSathyanath Rajasekharan
Sathyanath Rajasekharan
KBK. Adam Baker
K. Adam Baker
KHKatherine E. Horn
Katherine E. Horn
AJAndrew A. Jarjour
Andrew A. Jarjour
JAJack P. Antel
Jack P. Antel
TKTimothy E. Kennedy
Timothy E. Kennedy
The molecular mechanisms underlying the elaboration of branched processes during the later stages of oligodendrocyte maturation are not well understood. Here we describe a novel role for the chemotropic guidance cue netrin 1 and its receptor deleted in colorectal carcinoma (Dcc) in the remodeling of oligodendrocyte processes. Postmigratory, premyelinating oligodendrocytes express Dcc but not netrin 1, whereas mature myelinating oligodendrocytes express both. We demonstrate that netrin 1 promotes process extension by premyelinating oligodendrocytes in vitro and in vivo. Addition of netrin 1 to mature oligodendrocytes in vitro evoked a Dcc-dependent increase in process branching. Furthermore, expression of netrin 1 and Dcc by mature oligodendrocytes was required for the elaboration of myelin-like membrane sheets. Maturation of oligodendrocyte processes requires intracellular signaling mechanisms involving Fyn, focal adhesion kinase (FAK), neuronal Wiscott-Aldrich syndrome protein (N-WASP) and RhoA; however, the extracellular cues upstream of these proteins in oligodendrocytes are poorly defined. We identify a requirement for Src family kinase activity downstream of netrin-1-dependent process extension and branching. Using oligodendrocytes derived from Fyn knockout mice, we demonstrate that Fyn is essential for netrin-1-induced increases in process branching. Netrin 1 binding to Dcc on mature oligodendrocytes recruits Fyn to a complex with the Dcc intracellular domain that includes FAK and N-WASP, resulting in the inhibition of RhoA and inducing process remodeling. These findings support a novel role for netrin 1 in promoting oligodendrocyte process branching and myelin-like membrane sheet formation. These essential steps in oligodendroglial maturation facilitate the detection of target axons, a key step towards myelination.